Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Autolus Therapeutics (AUTL) Interest & Investment Income (2017 - 2025)

Historic Interest & Investment Income for Autolus Therapeutics (AUTL) over the last 9 years, with Q3 2025 value amounting to $4.4 million.

  • Autolus Therapeutics' Interest & Investment Income fell 4733.17% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.2 million, marking a year-over-year decrease of 1690.25%. This contributed to the annual value of $32.4 million for FY2024, which is 13957.79% up from last year.
  • According to the latest figures from Q3 2025, Autolus Therapeutics' Interest & Investment Income is $4.4 million, which was down 4733.17% from $5.2 million recorded in Q2 2025.
  • In the past 5 years, Autolus Therapeutics' Interest & Investment Income ranged from a high of $28.0 million in Q3 2021 and a low of $28000.0 during Q1 2022
  • For the 5-year period, Autolus Therapeutics' Interest & Investment Income averaged around $4.8 million, with its median value being $3.4 million (2023).
  • Per our database at Business Quant, Autolus Therapeutics' Interest & Investment Income surged by 7557567.57% in 2021 and then plummeted by 9941.07% in 2022.
  • Over the past 5 years, Autolus Therapeutics' Interest & Investment Income (Quarter) stood at $149000.0 in 2021, then skyrocketed by 857.05% to $1.4 million in 2022, then surged by 111.08% to $3.0 million in 2023, then skyrocketed by 147.41% to $7.4 million in 2024, then tumbled by 41.16% to $4.4 million in 2025.
  • Its last three reported values are $4.4 million in Q3 2025, $5.2 million for Q2 2025, and $6.1 million during Q1 2025.